# Healthy ageing without the hype: what a doctor-led assessment should actually include Canonical HTML source: [https://drluhard.com/insight-healthy-ageing-assessment-pretoria.html](https://drluhard.com/insight-healthy-ageing-assessment-pretoria.html) - Author and medical reviewer: **Dr Luhard Jansen van Vuuren, MBChB (Pret)** - Published and last reviewed: **1 November 2026** - Clinical setting: Dr Luhard consults patients through **Medify**, the separate patient-care practice in Waterkloof, Pretoria. Healthy ageing is not a biological-age score, an automatic hormone prescription or a universal peptide-and-supplement stack. It is a personalised medical strategy designed to preserve health, function and quality of life by identifying modifiable risks, treating defined problems and monitoring what matters. > **The short answer:** healthy ageing means maintaining the functional ability to live well. A responsible assessment asks what threatens that function now, what is realistically modifiable and how progress will be measured. ## Healthy ageing and anti-ageing are not identical The World Health Organization defines healthy ageing around functional ability: being able to meet basic needs, learn and make decisions, remain mobile, maintain relationships and contribute to society. Aesthetic treatment can support confidence, but appearance is not a substitute for cardiometabolic health, strength, cognition, sleep, mobility or social wellbeing. “Anti-ageing” is often used as a marketing label. It becomes medically useful only when translated into defined questions: Is blood pressure controlled? Is weight or waist trajectory increasing risk? Is the patient becoming weaker? Is sleep restorative? Is a symptom caused by a hormone disorder, medicine, nutritional problem or something else? ## Start with goals, risks and baseline function A consultation should begin with the person rather than a fixed panel. Depending on age, history and priorities, assessment may include: - medical and family history, previous diagnoses and current symptoms; - medicines, hormones, peptides and supplements already being used; - weight trajectory, waist circumference or body composition where useful; - blood pressure and cardiometabolic risk; - nutrition, alcohol, smoking, activity and recovery; - sleep, mood, cognition, sexual health and quality of life; - strength, mobility, balance and day-to-day function; - appropriate examination, screening, investigation or referral. Testing earns its place when the result can change diagnosis, treatment or monitoring. More biomarkers do not automatically produce better care. ## Cardiometabolic health and weight Weight management can form part of healthy ageing when excess adiposity is affecting health or future risk. Medically assisted treatment should sit inside longitudinal care that also addresses nutrition, physical activity, sleep, adverse effects, body composition and maintenance. Prescription treatment is not simply a cosmetic shortcut. It should have a clinical indication, realistic objective and follow-up plan. See [Dr Luhard's medical weight-loss approach](https://drluhard.com/medical-weight-loss-pretoria.html). ## Muscle, movement and physical capacity Strength and function matter because healthy ageing is about what a person can continue to do. During substantial weight loss, the plan should consider nutrition, resistance exercise and clinically relevant body-composition or functional trends. Lean mass is not identical to skeletal muscle, and no single measurement tells the whole story. Read [why preserving muscle matters during medical weight loss](https://drluhard.com/insight-preserving-muscle-during-medical-weight-loss.html). ## Hormone health: diagnosis before optimisation Fatigue, weight change, poor sleep, reduced libido and mood symptoms are not specific to one hormone disorder. Responsible care combines symptoms and context with appropriate investigations before treatment is considered. Hormone treatment should address a defined clinical problem. It is not automatically indicated because a patient is ageing, and the objective is not to push every result to the upper end of a reference range. See the [assessment-first hormone-health framework](https://drluhard.com/hormone-health-pretoria.html). ## Nutrition and targeted supplementation There is no universal longevity supplement stack. A supplement should address a demonstrated deficiency, predictable nutritional gap, specific clinical need or treatment-related risk. Dose, quality, interactions, duration and review point matter. Supplements can interact with medicines and should not replace a healthy dietary pattern or prescribed treatment. Read the [targeted-supplementation framework](https://drluhard.com/targeted-supplementation-pretoria.html). ## Peptides and emerging interventions “Peptide” describes a broad group, not one evidence category. Approved medicines, off-label uses, compounded products, investigational substances and products sold informally cannot be treated as interchangeable. Evidence, manufacturing quality, regulatory status and patient suitability must be assessed product by product. Some substances marketed online for recovery, body composition or longevity remain unregistered or inadequately supported by human evidence. A consultation does not guarantee access or a prescription. Read about [responsible peptide care](https://drluhard.com/peptide-therapy-pretoria.html). ## What a healthy-ageing consultation may produce A useful consultation may lead to: 1. a prioritised plan for modifiable health risks; 2. targeted investigations or appropriate screening; 3. review of medicines, hormones, peptides and supplements already used; 4. an individual nutrition, activity, sleep or weight-management strategy; 5. treatment only when clinically justified; 6. referral when another professional is better placed to help; 7. defined outcomes and a follow-up interval; 8. stopping something unnecessary or potentially harmful. The correct outcome is not always more treatment. ## What responsible care does not promise Responsible healthy-ageing care does not promise to reverse biological ageing, guarantee hormones or peptides, use one laboratory panel for everyone, prescribe a universal supplement stack or claim certainty beyond the evidence. ## Frequently asked questions ### What is the difference between healthy ageing and anti-ageing medicine? Healthy ageing focuses on maintaining health, function and quality of life. “Anti-ageing” is a broad marketing term unless it is translated into defined, measurable clinical goals. ### Which blood tests are used? There is no universal panel. Testing is selected from the history, examination, risk profile and clinical question when the result could change care. ### Does everyone need hormones, peptides or supplements? No. Each intervention needs its own indication, evidence, risk assessment and monitoring plan. ### Can GLP-1 treatment form part of healthy ageing? It can form part of doctor-led obesity care for an appropriate patient. It is not a standalone longevity treatment and should be integrated with nutrition, activity, monitoring and long-term planning. ### Are peptides proven to slow ageing? There is no basis for treating all peptides as proven anti-ageing therapy. Evidence and regulatory status differ substantially between products, and many longevity claims exceed available human evidence. ### Where does Dr Luhard consult? Dr Luhard consults through Medify at 265 Main Street, Waterkloof, Pretoria. [Request a consultation](https://wa.me/27655595412) or [view Medify's current patient price list](https://themedify.com/price-list.html). ## Sources and further reading - [World Health Organization: healthy ageing and functional ability](https://www.who.int/news-room/questions-and-answers/item/healthy-ageing-and-functional-ability) - [World Health Organization: Integrated care for older people, second edition](https://www.who.int/publications/i/item/9789240103726) - [World Health Organization: guideline on GLP-1 medicines for obesity](https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity) - [Endocrine Society: 2026 statement on testosterone replacement therapy](https://www.endocrine.org/news-and-advocacy/news-room/2026/statement-on-testosterone%20replacement-therapy) - [NIH Office of Dietary Supplements: what you need to know](https://ods.od.nih.gov/factsheets/WYNTK-Consumer/) - [SAHPRA: public information on peptide products](https://www.sahpra.org.za/peptide-products-public-information/) Medical disclaimer: This article provides general medical information. It does not replace an individual consultation, diagnosis, screening recommendation or treatment plan. Suitability is determined for the individual patient.